BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23679245)

  • 1. Prognostic value of matrix metalloproteinase 9 expression in breast cancer patients: a meta-analysis.
    Song J; Su H; Zhou YY; Guo LL
    Asian Pac J Cancer Prev; 2013; 14(3):1615-21. PubMed ID: 23679245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
    PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of matrix metalloproteinase 2 on prognosis and clinicopathology of breast cancer patients: a systematic meta-analysis.
    Chen Y; Wang X; Chen G; Dong C; Zhang D
    PLoS One; 2015; 10(3):e0121404. PubMed ID: 25816052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of β-catenin Expression in Breast Cancer Patients: a Meta-analysis.
    Zhang DP; Li XW; Lang JH
    Asian Pac J Cancer Prev; 2015; 16(14):5625-33. PubMed ID: 26320427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of survivin expression in breast cancer patients: a meta-analysis.
    Song J; Su H; Zhou YY; Guo LL
    Tumour Biol; 2013 Aug; 34(4):2053-62. PubMed ID: 23690235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of survivin in breast cancer: meta-analysis.
    Li Y; Ma X; Wu X; Liu X; Liu L
    Breast J; 2014; 20(5):514-24. PubMed ID: 25041354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Role of Matrix Metalloproteinases in Cervical Cancer: A Meta-Analysis.
    Chen W; Huang S; Shi K; Yi L; Liu Y; Liu W
    Cancer Control; 2021; 28():10732748211033743. PubMed ID: 34482737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis.
    Jiang H; Li H
    BMC Cancer; 2021 Feb; 21(1):149. PubMed ID: 33568081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase 9 expression and prognosis in colorectal cancer: a meta-analysis.
    Li CY; Yuan P; Lin SS; Song CF; Guan WY; Yuan L; Lai RB; Gao Y; Wang Y
    Tumour Biol; 2013 Apr; 34(2):735-41. PubMed ID: 23269605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of matrix metalloproteinase-9 in gastric cancer: a meta-analysis.
    Chen J; Chen LJ; Zhou HC; Yang RB; Lu Y; Xia YL; Wu W; Hu LW
    Hepatogastroenterology; 2014; 61(130):518-24. PubMed ID: 24901174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of matrix metalloproteinase 9 in nasopharyngeal carcinoma: a meta-analysis.
    Liao D; Huang H; Zhu Z; Li T; Li H; Huang GL; He Z
    Minerva Med; 2016 Feb; 107(1):54-61. PubMed ID: 26799856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
    Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
    Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-9 as a prognostic factor in gastric cancer: a meta-analysis.
    Zhang QW; Liu L; Chen R; Wei YQ; Li P; Shi HS; Zhao YW
    Asian Pac J Cancer Prev; 2012; 13(6):2903-8. PubMed ID: 22938481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of MMP-7 expression in colorectal cancer: a meta-analysis.
    Sun DW; Zhang YY; Qi Y; Zhou XT; Lv GY
    Cancer Epidemiol; 2015 Apr; 39(2):135-42. PubMed ID: 25677090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
    Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
    Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9) and aminopeptidase N/CD13 in breast cancer patients.
    Ranogajec I; Jakić-Razumović J; Puzović V; Gabrilovac J
    Med Oncol; 2012 Jun; 29(2):561-9. PubMed ID: 21611838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of High VEGF-C Expression for Patients with Breast Cancer: An Update Meta Analysis.
    Zhang Z; Luo G; Tang H; Cheng C; Wang P
    PLoS One; 2016; 11(11):e0165725. PubMed ID: 27812168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological and prognostic significance of cyclin D1 amplification in patients with breast cancer: a meta-analysis.
    He Q; Wu J; Liu XL; Ma YH; Wu XT; Wang WY; An HX
    J BUON; 2017; 22(5):1209-1216. PubMed ID: 29135104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of MMP-9 in ovarian cancer: a meta-analysis.
    Li LN; Zhou X; Gu Y; Yan J
    Asian Pac J Cancer Prev; 2013; 14(7):4107-13. PubMed ID: 23991961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.